What is ELAB's market cap?

$1.55M, based on the Nov 4 close of $1.92.

Does PMGC Holdings pay a dividend?

No regular cash dividend has been paid in the last year.

How much of ELAB is sold short?

18.5K shares, 0.4% of float, as of Oct 15, 2026.

What sector is ELAB in?

Healthcare, in the Pharmaceuticals industry.

NASDAQ · ELABHealthcarePharmaceuticals

PMGC Holdings Inc. Common Stock (ELAB)

$1.92−1.03%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$1.92▼ 99.86% in range

Nov 4, 2025Low $1.92 · High $1382.40Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

PMGC Holdings closed at $1.92 on Nov 4, down 1.03%, within 0.0% of its 52-week closing low. Volume of 109.2K shares was 0.17× its 20-day average (below normal).

Split-adjusted performance: -41.3% over one month, -91.0% over six months, -99.9% over one year.

In the quarter ended Jun 30, 2026, revenue was $1.31M, with a net margin of -225.1%.

Short interest was 18.5K shares at the Oct 15 settlement, down 32.9% from the prior report (0.4% of float, 1.0 days to cover).

Market cap$1.6M809.6K shares

Revenue · quarter$1.3M—

Diluted EPS$-6.03—

P/E · TTM—P/S 0.6×

Net margin-225.1%Gross 29.5%

Dividend yieldNone

52-week range1.92 – 1435.20−99.9% from high

Volume109.2K0.17× 20-day avg

Volatility · 60d677.7%Annualised

Short % of float0.4%1.0 days to cover

Net cash$9.4MCash $18.8M

Next earnings—Not scheduled

Split-adjusted performance

1W −25.3%1M −41.3%3M −79.9%6M −91.0%YTD −99.5%1Y −99.9%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum2

Revenue growth—

Net margin35

Value (low P/E)—

Size2

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short18.5K−32.9% vs prior

Days to cover1.0Settled Oct 15

% of float0.4%

Short vol. 10d47.8%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
ELABPMGC Holdings	$1.92	−1.03%	−91.0%	—	−225.1%	—	$1.6M
GOVXGeoVax Labs, Inc. New	$0.1680	+2.38%	−89.8%	−100.0%	—	—	$1.5M	Compare
KPTIKaryopharm Therapeutics	$0.0729	−17.44%	−99.2%	−11.9%	−200.5%	—	$1.7M	Compare
KAPAKairos Pharma	$0.4897	−3.03%	−87.4%	—	—	—	$1.7M	Compare
OGENOragenics	$0.3720	+0.51%	−40.0%	—	—	—	$1.7M	Compare
GNPXGenprex	$2.14	−7.36%	−89.1%	—	—	—	$1.8M	Compare
PPCBPropanc Biopharma	$1.79	+4.68%	−92.9%	—	—	—	$1.8M	Compare
ARTLArtelo Biosciences	$2.27	−5.42%	−90.9%	—	—	—	$1.2M	Compare
SBFMSunshine Biopharma	$2.65	−3.28%	−98.8%	−1.6%	−16.9%	—	$2.0M	Compare

News about PMGC Holdings

All news →

PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health HoldingsGlobeNewswire Inc. · Sep 18, 2026▲ Positive PMGC Holdings Confirms Compliance with Nasdaq’s New $5 Million Market Value of Listed Securities RequirementGlobeNewswire Inc. · Jul 29, 2026▲ Positive NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen ExpressionGlobeNewswire Inc. · Jul 10, 2026▲ Positive NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva BiosciencesGlobeNewswire Inc. · Jul 1, 2026▲ Positive PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor MarketsBenzinga · Jun 1, 2026▲ Positive

Quick answers

What does PMGC Holdings do?: PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
What is ELAB's market cap?: $1.55M, based on the Nov 4 close of $1.92.
Does PMGC Holdings pay a dividend?: No regular cash dividend has been paid in the last year.
How much of ELAB is sold short?: 18.5K shares, 0.4% of float, as of Oct 15, 2026.
What sector is ELAB in?: Healthcare, in the Pharmaceuticals industry.

About PMGC Holdings

PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

HQ: Newport Beach, CA34 employeesListed Nov 21, 2023pmgcholdings.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology